GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (SHSE:603259) » Definitions » EBITDA Margin %

Wuxi AppTec Co (SHSE:603259) EBITDA Margin % : 45.01% (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Wuxi AppTec Co's EBITDA for the three months ended in Mar. 2025 was ¥4,346 Mil. Wuxi AppTec Co's Revenue for the three months ended in Mar. 2025 was ¥9,655 Mil. Therefore, Wuxi AppTec Co's EBITDA margin for the quarter that ended in Mar. 2025 was 45.01%.


Wuxi AppTec Co EBITDA Margin % Historical Data

The historical data trend for Wuxi AppTec Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuxi AppTec Co EBITDA Margin % Chart

Wuxi AppTec Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.30 32.18 31.56 35.12 37.05

Wuxi AppTec Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.42 30.33 27.22 32.51 45.01

Competitive Comparison of Wuxi AppTec Co's EBITDA Margin %

For the Diagnostics & Research subindustry, Wuxi AppTec Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuxi AppTec Co's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Wuxi AppTec Co's EBITDA Margin % falls into.


;
;

Wuxi AppTec Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Wuxi AppTec Co's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=14538.022/39241.431
=37.05 %

Wuxi AppTec Co's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=4345.655/9654.595
=45.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuxi AppTec Co  (SHSE:603259) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Wuxi AppTec Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuxi AppTec Co Business Description

Traded in Other Exchanges
Address
288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by China, Europe, and other regions.
Executives
Chen Shu Hui senior management
Yang Director
Hu Zheng Guo Director
senior management
Yao Chi Director
Chen Min Director
Zhu Bi Xin senior management
Yang senior management
Chen Shu Hui senior management
Hu Zheng Guo Director

Wuxi AppTec Co Headlines

No Headlines